Catherine L. Parrott
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Catherine L. Parrott.
Journal of Clinical Investigation | 1995
V S Kashyap; Silvia Santamarina-Fojo; David R. Brown; Catherine L. Parrott; Deborah Applebaum-Bowden; S Meyn; Talley Gd; B Paigen; Nobuyo Maeda; H B Brewer
Apolipoprotein E (apoE)-deficient mice develop marked hyperlipidemia as well as atherosclerosis and thus are an excellent animal model for evaluating the potential for gene therapy in human genetic dyslipoproteinemias. Recombinant adenovirus containing either human apoE (rAdv.apoE) or the reporter gene luciferase (rAdv.luc) were generated and infused intravenously in apoE-deficient mice with preinfusion plasma total cholesterol of 644 +/- 149 mg/dl an cholesterol rich VLDL/IDL. After a single infusion of rAdv.apoE, plasma concentrations of human apoE ranging from 1.5 to 650 mg/dl were achieved. Adenovirus-mediated apoE replacement resulted in normalization of the lipid and lipoprotein profile with markedly decreased total cholesterol (103 +/- 18mg/dl), VLDL, IDL, and LDL, as well as increased HDL. Measurement of aortic atherosclerosis 1 mo after adenoviral infusion demonstrated a marked reduction in the mean lesion area of mice infused with rAdv.apoE (58 +/- 8 x 10(3) microns2) when compared with control mice infused with rAdv.luc (161 +/- 10 x 10(3) microns2; P < 0.0001). Thus, apoE expression for 4 wk was sufficient to markedly reduce atherosclerosis, demonstrating the feasibility of gene therapy for correction of genetic hyperlipidemias resulting in atherosclerosis. The combined use of adenovirus vectors and the apoE-deficient mouse represents a new in vivo approach that will permit rapid screening of candidate genes for the prevention of atherosclerosis.
Journal of Clinical Investigation | 1996
Applebaum-Bowden D; Junji Kobayashi; V S Kashyap; David R. Brown; Berard A; S Meyn; Catherine L. Parrott; Nobuyo Maeda; Robert D. Shamburek; H B Brewer; Silvia Santamarina-Fojo
Hepatic lipase (HL) is an endothelial-bound lipolytic enzyme which functions as a phospholipase as well as a triacylglycerol hydrolase and is necessary for the metabolism of IDL and HDL. To evaluate the feasibility of replacing an enzyme whose in vivo physiologic function depends on its localization on the vascular endothelium, we have infused recombinant replication-deficient adenovirus vectors expressing either human HL (HL-rAdV; n = 7) or luciferase cDNA (Lucif-rAdV; n = 4) into HL-deficient mice with pretreatment plasma cholesterol, phospholipid, and HDL cholesterol values of 176 +/- 9, 314 +/- 12, and 129 +/- 9, respectively. After infusion of HL-rAdV, HL could be detected in the postheparin plasma of HL-deficient mice by immunoblotting and postheparin plasma HL activities were 25,700 +/- 4,810 and 1,510 +/- 688 nmol/min/ml on days 5 and 15, respectively. Unlike the mouse HL, 97% of the newly synthesized human HL was heparin releasable, indicating that the human enzyme was virtually totally bound to the mouse vascular endothelium. Infusion of HL-rAdV in HL-deficient mice was associated with a 50-80% decrease in total cholesterol, triglyceride, phospholipids, cholesteryl ester, and HDL cholesterol (P < 0.001) as well as normalization of the plasma fast protein liquid chromatography lipoprotein profile by day 8. These studies demonstrate successful expression and delivery of a lipolytic enzyme to the vascular endothelium for ultimate correction of the HL gene defect in HL-deficient mice and indicate that recombinant adenovirus vectors may be useful in the replacement of endothelial-bound lipolytic enzymes in human lipolytic deficiency states.
Archives of Biochemistry and Biophysics | 1975
Sidney Shifrin; Catherine L. Parrott
Abstract Dissociation of tetrameric l -asparaginase from Escherichia coli B was examined in the presence of urea containing one of the following polyhydric alcohols: ethylene glycol, 1,2-propanediol, 1,3-propanediol, glycerol, erythritol, arabitol, adonitol, mannitol, sorbitol, inositol, glucose, sucrose, and polyethylene glycol. Low concentrations of these compounds accelerate the rate of subunit dissociation, and, with the exception of the propanediols and polyethylene glycol, higher concentrations decrease the rate at which the oligomeric enzyme dissociates. The specific concentration at which this transition occurs is related to the length of the carbon chain of the polyhydric alcohols and to the steric configuration of the hydroxyl groups about the asymmetric carbon atoms. In addition, the rate at which the oligomeric enzyme dissociates decreases as the number of hydroxymethyl groups per molecule polyol increases and reaches a maximum with the six carbon members. Low concentrations (1% by volume) of methanol, ethanol, ethylene glycol, propylene glycol, or glycerol contained in the renaturation buffer slightly accelerate the rate of reassembly of denatured subunits. The rate at which reassociation to the tetramer occurs also increases as the number of hydroxymethyl groups per molecule of polyhydric alcohol increases.
Biochimica et Biophysica Acta | 1977
Catherine L. Parrott; Sidney Shifrin
The absorption spectra of trinitrophenyl derivatives of poly(L-lysine) and L-asparaginase undergo irreversible changes in the presence of KBH4. The spectra of trinitrophenyl derivatives of N-acetyl-L-lysine and N-acetyl-L-cysteine are also affected by the addition of the reducing agent. A broad absorption band with a maximum at 426 nm appears in the presence of low concentrations of borohydride with a concomitant decrease in absorbance of the 346 nm band which is characteristic of 1-substituted 2,4,6-trinitrophenyl compounds. In the presence of higher concentrations of KBH4 the long wavelength band becomes less broad as the maximum is shifted to 410 nm and the 346 nm band completely disappears. Similar spectral changes were observed in the presence of Na2SO3 although these were reversible upon removal of the sulfite by dialysis. Based on the spectral similarities with sulfite and hydroxide adducts, we suggest that the 426 nm maximum represents a 1:1 adduct formed between the trinitrophenyl moiety and a hydride ion while the band at 410 nm is assigned to the 1:2 adduct.
Biochimica et Biophysica Acta | 1976
Catherine L. Parrott; Sidney Shifrin
L-Asparaginase (L-asparagine amidohydrolase, EC 3.5.1.1) from Escherichia coli B was modified by treatment with 2,4,6-trinitrobenzene-1-sulfonic acid at pH 7.5. The introduction of 13 trinitrophenyl groups into one mol of the tetrameric enzyme (TNP 13-asparaginase) results in a loss of 67% of the catalytic activity while the presence of 20 groups (TNP 20-asparaginase) reduces the enzymatic activity by 88%. The modified proteins are homogeneous as judged by disc gel electrophoresis and by the monodisperse boundary in the analytical ultracentrifuge having a sedimentation coefficient of 7.2 S. The rate of dissociation of the TNP 13-asparaginase is twice as fast and TNP 20-asparaginase three times as fast as that of unmodified asparaginase in 4 M urea. Trinitrophenylated subunits in 8 M urea can reassociate into the tetramer after removal of urea by dialysis or by dilution. hybridization of unmodified and TNP subunits indicates that that trinitrophenyl derivatives qualify as suitable variants for studying subunit interactions in oligomeric proteins.
Journal of Biological Chemistry | 1991
L Previato; Catherine L. Parrott; Silvia Santamarina-Fojo; H B Brewer
Journal of Lipid Research | 1993
H L Dichek; Catherine L. Parrott; R Ronan; J D Brunzell; H B Brewer; Silvia Santamarina-Fojo
Journal of Biological Chemistry | 1996
Junji Kobayashi; Deborah Applebaum-Bowden; Klaus A. Dugi; David R. Brown; Vikram S. Kashyap; Catherine L. Parrott; Cornelio J. Duarte; Nobuyo Maeda; Silvia Santamarina-Fojo
Journal of Lipid Research | 1992
Catherine L. Parrott; Naji Alsayed; Regis Rebourcet; Silvia Santamarina-Fojo
Journal of Biological Chemistry | 1974
Sidney Shifrin; Catherine L. Parrott